2027 Communication Dosage 
PharmaShots
FEBRUARY 22, 2023
Active Ingredient: dulaglutide Dosage Forms & Strengths: Injection: 0.75 In the US, Trulicity is protected by a compound patent (2027) and by biologics data protection (2026). mL, 3 mg/0.5
ISPE
MARCH 8, 2023
2 , 40 Although our analysis hinted at the US being most affected by recalls of contaminated medicinal products, 5 , 29 this could be explained by the fact that the US FDA regularly publishes alerts and recall notifications on their website to communicate recall information to consumers.
ISPE
SEPTEMBER 11, 2023
POD is suitable for a wide range of products, including oral solid dosage forms, mAbs, and cell therapy. Nature Communications 12, no. Review: Continuous Manufacturing of Small Molecule Solid Oral Dosage Forms.” The fit-for-purpose and reduced-size POD units promote green manufacturing. Biotechnology Progress 36, no.
Expert insights. Personalized for you.
64 
Let's personalize your content